Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population

References

• ATS/ERS. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818–900. doi:10.1164/rccm.168.7.81814522813
   PubMed Web of Science ®Google Scholar
• JanciauskieneSM, BalsR, KoczullaR, et al. The discovery of alpha1-antitrypsin and its role in health and disease. Respir Med. 2011;105:1129–1139. doi:10.1016/j.rmed.2011.02.00221367592
   PubMed Web of Science ®Google Scholar
• FulopT, KhalilA, LarbiA. The role of elastin peptides in modulating the immune response in aging and age-related diseases. Pathol Biol. 2012;60(1):28–33. doi:10.1016/j.patbio.2011.10.00622099332
   PubMedGoogle Scholar
• ErikssonS, CarlsonS, VelezR. Risk of cirrhosis and primary liver cancer in alpha-l-antitrypsin deficiency. N Engl J Med. 1986;314:736–739. doi:10.1056/NEJM1986032031412023485248
   PubMed Web of Science ®Google Scholar
• TanashH, PiitulainenE. Liver disease in adults with severe alpha 1-antitrypsin deficiency. J Gastroenterol. 2019;6:541–548. doi:10.1007/s00535-019-01548-y
   Web of Science ®Google Scholar
• SegelmarkM, ElzoukiAN, WieslanderJ, ErikssonS. The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int. 1995;48:844–850. doi:10.1038/ki.1995.3607474674
   PubMed Web of Science ®Google Scholar
• EdmondsBK, HodgeJA, RietschelRL. Alpha 1-antitrypsin deficiency- associated panniculitis: case report and review of the literature. Pediatr Dermatol. 1991;8:296–299. doi:10.1111/j.1525-1470.1991.tb00937.x1792202
   PubMed Web of Science ®Google Scholar
• DahlM, Tybjaerg-HansenA, SillesenH, JensenG, SteffensenR, NordestgaardBG. Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart Study. Circulation. 2003;107:747–752. doi:10.1161/01.CIR.0000049642.20484.5D12578879
   PubMed Web of Science ®Google Scholar
• FähndrichS, BiertzF, KarchA, et al. Cardiovascular risk in patients with alpha-1-antitrypsin deficiency. Respir Res. 2017;18(1):171. doi:10.1186/s12931-017-0655-128915894
   PubMed Web of Science ®Google Scholar
• PezziniA, MagoniM, CordaL, et al. Alpha-1-antitrypsin deficiency-associated cervical artery dissection: report of three cases. Eur Neurol. 2002;47(4):201–204. doi:10.1159/00005789912037432
   PubMed Web of Science ®Google Scholar
• VizzardiE, CordaL, PezzaliN, et al. Elastic properties of the ascending aorta in patients with alpha1-antitrypsin deficiency (Z homozygotes). Heart. 2012;98(18):1354–1358. doi:10.1136/heartjnl-2012-30214422851685
   PubMed Web of Science ®Google Scholar
• SchachnerT, GoldererG, SargB, et al. The amounts of alpha 1 antitrypsin protein are reduced in the vascular wall of the acutely dissected human ascending aorta. Eur J Cardiothorac Surg. 2010;37(3):684–690. doi:10.1016/j.ejcts.2009.07.02519709897
   PubMed Web of Science ®Google Scholar
• DuckersJM, ShaleDJ, StockleyRA, et al. Cardiovascular and musculoskeletal co-morbidities in patients with alpha-1-antitrypsin deficiency. Respir Res. 2010;11:173–179. doi:10.1186/1465-9921-11-17321138571
   PubMed Web of Science ®Google Scholar
• LuisettiM, SeersholmN. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax. 2004;59:164–169. doi:10.1136/thorax.2003.00649414760160
   PubMed Web of Science ®Google Scholar
• NowbarAN, HowardJP, FinegoldJA, et al. 2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations. Int J Cardiol. 2014;174:293–298. doi:10.1016/j.ijcard.2014.04.09624794549
   PubMed Web of Science ®Google Scholar
• DivoM, CoteC, de TorresJP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC22561964
   PubMed Web of Science ®Google Scholar
• PiitulainenE, TanashHA. The clinical profile of subjects included in the Swedish National Register on individuals with severe alpha 1-antitrypsin deficiency. COPD. 2015;1:36–41. doi:10.3109/15412555.2015.1021909
   Google Scholar
• TanashHA, EkströmM, RönmarkE, LindbergA, PiitulainenE. Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison with a general population with known smoking habits. Eur Respir J. 2017;50(3):1700198. doi:10.1183/13993003.00198-201728889108
   PubMed Web of Science ®Google Scholar
• RönmarkE, WarmK, BjergA, BackmanH, HedmanL, LundbäckB. High incidence and persistence of airborne allergen sensitization up to age 19 years. Allergy. 2017;72(5):723–730. doi:10.1111/all.1305327659134
   PubMed Web of Science ®Google Scholar
• LarssonLG, LindbergA, FranklinKA, LundbäckB. Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population. Respir Med. 2001;95:423–429. doi:10.1053/rmed.2001.105411392586
   PubMed Web of Science ®Google Scholar
• LudvigssonJF, AnderssonE, EkbomA, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450. doi:10.1186/1471-2458-11-45021658213
   PubMed Web of Science ®Google Scholar
• TanashHA, EkströmMP, WagnerP, PiitulainenE. Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison with the general population in Sweden. Int J Chron Obstruct Pulmon Dis. 2016;11:1663–1669. doi:10.2147/COPD.S10917327555756
   PubMed Web of Science ®Google Scholar
• DichtlW, MoragaF, AresMPS, et al. The carboxyl-terminal fragment of 1-antitrypsin is present in atherosclerotic plaques and regulates inflammatory transcription factors in primary human monocytes. Mol Cell Biol Res Commun. 2000;4:50–61. doi:10.1006/mcbr.2000.025611152628
   PubMedGoogle Scholar
• GreulichT, NellC, HohmannD, et al. The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database. Eur Respir J. 2017;49(1):1600154. doi:10.1183/13993003.00154-201627824593
   PubMed Web of Science ®Google Scholar
• CarterP, LaganJ, FortuneC, et al. Association of cardiovascular disease with respiratory disease. J Am Coll Cardiol. 2019;73(17):2166–2177. doi:10.1016/j.jacc.2018.11.06330846341
   PubMed Web of Science ®Google Scholar
• JönssonA, FedorowskiA, EngströmG, WollmerP, HamreforsV. High prevalence of undiagnosed COPD among patients evaluated for suspected myocardial ischaemia. Open Heart. 2018;5(2):e000848. doi:10.1136/openhrt-2018-00084830402258
   PubMed Web of Science ®Google Scholar